Preventive Vaccine market by Vaccine Type (Live, Attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines), by End User (Paediatric and Adult Vaccines) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Preventive Vaccine market by Vaccine Type (Live, Attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines), by End User (Paediatric and Adult Vaccines) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 160 | Pages: 175 | December 2016 | Region: Global


The Global Preventive Vaccine market is estimated at $30.24 Billion in 2015 and is poised to reach $55 billion by 2020 with a compound annual growth rate of 12.74%. The vaccine market accounts for only 5 % of the global pharmaceuticals market. However, recently there has been a substantial growth owing to the rising incidences of cancer & HIV cases. Nevertheless, there has been rapid growth over recent years, with the vaccine market magnifying in value from USD 5 billion in 2000 to almost USD 25 billion in 2013. World Health Organization growth estimations indicate the market may increase in value to almost 60 billion 2020, with the arrival of new therapeutic, preventive and adult vaccines.

The vaccine Market is different from any other product market. Compared to the pharmaceutical market it is relatively small, although growing at a fast rate. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. The vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features which increase the complexity of assessing and understanding pricing and procurement in their context.

Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements to decrease the new vaccine development time, initiatives by NGO’s are some of the factors that are propelling the vaccines market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.

The Global Preventive Vaccines Market is segmented by type of vaccine as Live, attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines. In addition, based on age groups the market is categorized as Paediatric Vaccine (Pneumococcal, MMR, Varicella, Hepatitis, Poliovirus, HIB and others) and Adult vaccines (Influenza, Cervical Cancer, Hepatitis, Zoster and others). Furthermore, based on geography the global market is analysed under various regions namely, North America, Europe, Asia Pacific, Latin America and Middle-East & Africa. North America accounts for the large portion of revenue in the therapeutic vaccine market. The growth of this market will be boosted owing to the presence of advanced and active R&D establishments in the region.

Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production. They have used significant revenues, global size, and deeper expertise to fund. Some of the key players influencing the global preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Vaccine Type                       

                                5.1.1 Live, Attenuated Vaccines

                                5.1.2 Inactivted Vaccines             

                                5.1.3 Toxoid Vaccines    

                                5.1.4 Subunit vaccines  

                                5.1.5 Conjugate vaccines             

                                5.1.6 DNA vaccines         

                                5.1.7 Recombinant vector vaccines          

                5.2 By End User               

                                5.2.1 Paediatric Vaccine

                                                5.2.1.1 Pneumococcal

                                                5.2.1.2 MMR

                                                5.2.1.3 Varicella

                                                5.2.1.4 Hepatitis

                                                5.2.1.5 Poliovirus

                                                5.2.1.6 HIB

                                                5.2.1.7 Others

                                5.2.2 Adult Vaccines      

                                                5.2.2.1 Influenza

                                                5.2.2.2 Cervical Cancer

                                                5.2.2.3 Hepatitis

                                                5.2.2.4 Zoster

                                                5.2.2.5 Others

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 GlaxoSmithKline, plc.                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Merck and Company                              

                8.3 Bavarian Nordic                        

                8.4 CSL Limited                 

                8.5 Emergent BioSolutions Inc.                  

                8.6 Novartis AG                

                8.7 Johnson and Johnson                             

                8.8 MedImmune, LLC                    

                8.9 Pfizer, Inc.                   

                8.10 Sanofi Pasteur                        

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Preventive Vaccines Market By Region, From 2015-2020 ( USD Billion )
  2. Global Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  3. Global Live, Attenuated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  4. Global Inactivated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  5. Global Toxoid Vaccines Market By Region, From 2015-2020 ( USD Billion )
  6. Global Subunit vaccines Market By Region, From 2015-2020 ( USD Billion )
  7. Global Conjugate vaccines Market By Region, From 2015-2020 ( USD Billion )
  8. Global DNA vaccines Market By Region, From 2015-2020 ( USD Billion )
  9. Global Recombinant vector vaccines Market By Region, From 2015-2020 ( USD Billion )
  10. Global Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  11. Global Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  12. Global Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  13. Global Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  14. Global Pneumococcal Vaccines Market By Region, From 2015-2020 ( USD Billion )
  15. Global MMR Vaccines Market By Region, From 2015-2020 ( USD Billion )
  16. Global Varicella Vaccines Market By Region, From 2015-2020 ( USD Billion )
  17. Global Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  18. Global Poliovirus Vaccines Market By Region, From 2015-2020 ( USD Billion )
  19. Global HIB Vaccines Market By Region, From 2015-2020 ( USD Billion )
  20. Global Other Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  21. Global Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  22. Global Influenza Vaccines Market By Region, From 2015-2020 ( USD Billion )
  23. Global Cervical Cancer Vaccines Market By Region, From 2015-2020 ( USD Billion )
  24. Global Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  25. Global Zoster Vaccines Market By Region, From 2015-2020 ( USD Billion )
  26. Global Other Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  27. North America Preventive Vaccines Market By Region, From 2015-2020 ( USD Billion )
  28. North America Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  29. North America Live, Attenuated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  30. North America Inactivated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  31. North America Toxoid Vaccines Market By Region, From 2015-2020 ( USD Billion )
  32. North America Subunit vaccines Market By Region, From 2015-2020 ( USD Billion )
  33. North America Conjugate vaccines Market By Region, From 2015-2020 ( USD Billion )
  34. North America DNA vaccines Market By Region, From 2015-2020 ( USD Billion )
  35. North America Recombinant vector vaccines Market By Region, From 2015-2020 ( USD Billion )
  36. North America Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  37. North America Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  38. North America Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  39. North America Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  40. North America Pneumococcal Vaccines Market By Region, From 2015-2020 ( USD Billion )
  41. North America MMR Vaccines Market By Region, From 2015-2020 ( USD Billion )
  42. North America Varicella Vaccines Market By Region, From 2015-2020 ( USD Billion )
  43. North America Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  44. North America Poliovirus Vaccines Market By Region, From 2015-2020 ( USD Billion )
  45. North America HIB Vaccines Market By Region, From 2015-2020 ( USD Billion )
  46. North America Other Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  47. North America Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  48. North America Influenza Vaccines Market By Region, From 2015-2020 ( USD Billion )
  49. North America Cervical Cancer Vaccines Market By Region, From 2015-2020 ( USD Billion )
  50. North America Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  51. North America Zoster Vaccines Market By Region, From 2015-2020 ( USD Billion )
  52. North America Other Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  53. United States Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  54. United States Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  55. Canada Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  56. Canada Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  57. United States Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  58. Canada Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  59. United States Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  60. Canada Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  61. Europe Preventive Vaccines Market By Region, From 2015-2020 ( USD Billion )
  62. Europe Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  63. Europe Live, Attenuated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  64. Europe Inactivated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  65. Europe Toxoid Vaccines Market By Region, From 2015-2020 ( USD Billion )
  66. Europe Subunit vaccines Market By Region, From 2015-2020 ( USD Billion )
  67. Europe Conjugate vaccines Market By Region, From 2015-2020 ( USD Billion )
  68. Europe DNA vaccines Market By Region, From 2015-2020 ( USD Billion )
  69. Europe Recombinant vector vaccines Market By Region, From 2015-2020 ( USD Billion )
  70. Europe Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  71. Europe Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  72. Europe Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  73. Europe Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  74. Europe Pneumococcal Vaccines Market By Region, From 2015-2020 ( USD Billion )
  75. Europe MMR Vaccines Market By Region, From 2015-2020 ( USD Billion )
  76. Europe Varicella Vaccines Market By Region, From 2015-2020 ( USD Billion )
  77. Europe Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  78. Europe Poliovirus Vaccines Market By Region, From 2015-2020 ( USD Billion )
  79. Europe HIB Vaccines Market By Region, From 2015-2020 ( USD Billion )
  80. Europe Other Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  81. Europe Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  82. Europe Influenza Vaccines Market By Region, From 2015-2020 ( USD Billion )
  83. Europe Cervical Cancer Vaccines Market By Region, From 2015-2020 ( USD Billion )
  84. Europe Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  85. Europe Zoster Vaccines Market By Region, From 2015-2020 ( USD Billion )
  86. Europe Other Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  87. U.K. Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  88. U.K. Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  89. Germany Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  90. Germany Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  91. France Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  92. France Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  93. Italy Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  94. Italy Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  95. Spain Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  96. Spain Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  97. U.K. Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  98. Germany Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  99. France Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  100. Italy Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  101. Spain Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  102. U.K. Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  103. Germany Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  104. France Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  105. Italy Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  106. Spain Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  107. Asia-Pacific Preventive Vaccines Market By Region, From 2015-2020 ( USD Billion )
  108. Asia-Pacific Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  109. Asia-Pacific Live, Attenuated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  110. Asia-Pacific Inactivated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  111. Asia-Pacific Toxoid Vaccines Market By Region, From 2015-2020 ( USD Billion )
  112. Asia-Pacific Subunit vaccines Market By Region, From 2015-2020 ( USD Billion )
  113. Asia-Pacific Conjugate vaccines Market By Region, From 2015-2020 ( USD Billion )
  114. Asia-Pacific DNA vaccines Market By Region, From 2015-2020 ( USD Billion )
  115. Asia-Pacific Recombinant vector vaccines Market By Region, From 2015-2020 ( USD Billion )
  116. Asia-Pacific Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  117. Asia-Pacific Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  118. Asia-Pacific Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  119. Asia-Pacific Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  120. Asia-Pacific Pneumococcal Vaccines Market By Region, From 2015-2020 ( USD Billion )
  121. Asia-Pacific MMR Vaccines Market By Region, From 2015-2020 ( USD Billion )
  122. Asia-Pacific Varicella Vaccines Market By Region, From 2015-2020 ( USD Billion )
  123. Asia-Pacific Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  124. Asia-Pacific Poliovirus Vaccines Market By Region, From 2015-2020 ( USD Billion )
  125. Asia-Pacific HIB Vaccines Market By Region, From 2015-2020 ( USD Billion )
  126. Asia-Pacific Other Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  127. Asia-Pacific Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  128. Asia-Pacific Influenza Vaccines Market By Region, From 2015-2020 ( USD Billion )
  129. Asia-Pacific Cervical Cancer Vaccines Market By Region, From 2015-2020 ( USD Billion )
  130. Asia-Pacific Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  131. Asia-Pacific Zoster Vaccines Market By Region, From 2015-2020 ( USD Billion )
  132. Asia-Pacific Other Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  133. China Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  134. China Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  135. India Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  136. India Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  137. Japan Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  138. Japan Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  139. South Korea Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  140. South Korea Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  141. China Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  142. India Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  143. Japan Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  144. South Korea Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  145. China Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  146. India Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  147. Japan Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  148. South Korea Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  149. Latin America Preventive Vaccines Market By Region, From 2015-2020 ( USD Billion )
  150. Latin America Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  151. Latin America Live, Attenuated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  152. Latin America Inactivated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  153. Latin America Toxoid Vaccines Market By Region, From 2015-2020 ( USD Billion )
  154. Latin America Subunit vaccines Market By Region, From 2015-2020 ( USD Billion )
  155. Latin America Conjugate vaccines Market By Region, From 2015-2020 ( USD Billion )
  156. Latin America DNA vaccines Market By Region, From 2015-2020 ( USD Billion )
  157. Latin America Recombinant vector vaccines Market By Region, From 2015-2020 ( USD Billion )
  158. Latin America Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  159. Latin America Pediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  160. Latin America Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  161. Latin America Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  162. Latin America Pneumococcal Vaccines Market By Region, From 2015-2020 ( USD Billion )
  163. Latin America MMR Vaccines Market By Region, From 2015-2020 ( USD Billion )
  164. Latin America Varicella Vaccines Market By Region, From 2015-2020 ( USD Billion )
  165. Latin America Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  166. Latin America Poliovirus Vaccines Market By Region, From 2015-2020 ( USD Billion )
  167. Latin America HIB Vaccines Market By Region, From 2015-2020 ( USD Billion )
  168. Latin America Other Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  169. Latin America Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  170. Latin America Influenza Vaccines Market By Region, From 2015-2020 ( USD Billion )
  171. Latin America Cervical Cancer Vaccines Market By Region, From 2015-2020 ( USD Billion )
  172. Latin America Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  173. Latin America Zoster Vaccines Market By Region, From 2015-2020 ( USD Billion )
  174. Latin America Other Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  175. Brazil Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  176. Brazil Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  177. Argentina Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  178. Argentina Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  179. Mexico Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  180. Mexico Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  181. Brazil Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  182. Argentina Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  183. Mexico Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  184. Brazil Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  185. Argentina Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  186. Mexico Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  187. Middle East & Africa Preventive Vaccines Market By Region, From 2015-2020 ( USD Billion )
  188. Middle East & Africa Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  189. Middle East & Africa Live, Attenuated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  190. Middle East & Africa Inactivted Vaccines Market By Region, From 2015-2020 ( USD Billion )
  191. Middle East & Africa Toxoid Vaccines Market By Region, From 2015-2020 ( USD Billion )
  192. Middle East & Africa Subunit vaccines Market By Region, From 2015-2020 ( USD Billion )
  193. Middle East & Africa Conjugate vaccines Market By Region, From 2015-2020 ( USD Billion )
  194. Middle East & Africa DNA vaccines Market By Region, From 2015-2020 ( USD Billion )
  195. Middle East & Africa Recombinant vector vaccines Market By Region, From 2015-2020 ( USD Billion )
  196. Middle East & Africa Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  197. Middle East & Africa Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  198. Middle East & Africa Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  199. Middle East & Africa Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  200. Middle East & Africa Pneumococcal Vaccines Market By Region, From 2015-2020 ( USD Billion )
  201. Middle East & Africa MMR Vaccines Market By Region, From 2015-2020 ( USD Billion )
  202. Middle East & Africa Varicella Vaccines Market By Region, From 2015-2020 ( USD Billion )
  203. Middle East & Africa Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  204. Middle East & Africa Poliovirus Vaccines Market By Region, From 2015-2020 ( USD Billion )
  205. Middle East & Africa HIB Vaccines Market By Region, From 2015-2020 ( USD Billion )
  206. Middle East & Africa Other Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  207. Middle East & Africa Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  208. Middle East & Africa Influenza Vaccines Market By Region, From 2015-2020 ( USD Billion )
  209. Middle East & Africa Cervical Cancer Vaccines Market By Region, From 2015-2020 ( USD Billion )
  210. Middle East & Africa Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  211. Middle East & Africa Zoster Vaccines Market By Region, From 2015-2020 ( USD Billion )
  212. Middle East & Africa Other  Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  213. Middle East Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  214. Middle East Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  215. Africa Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  216. Africa Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  217. Middle East Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  218. Africa Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  219. Middle East Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  220. Africa Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
Middle East And Africa Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, G...
Latin America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Asia Pacific Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tre...
Europe Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, A...
North America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Fore...
Middle East And Africa Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extre...
Latin America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Asia Pacific Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepin...
Europe Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, C...
North America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, Cataplex...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.